Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/1996
10/29/1996US5569584 Method for distinguishing or monitoring the state of premalignant or malignant transformed human colonic tissue
10/29/1996US5569454 Methods of treating infection using natural killer stimulatory factor
10/29/1996CA1338682C Biologically active undenatured whey protein concentrate as food supplement
10/24/1996WO1996033279A2 Repertoire cloning process, products derived therefrom and uses for said products
10/24/1996WO1996033276A1 NUCLEOTIDE SEQUENCE OF THE HAEMOPHILUS INFLUENZAE Rd GENOME, FRAGMENTS THEREOF, AND USES THEREOF
10/24/1996WO1996033275A1 H. INFLUENZAE HxuB AND HxuC GENES, PROTEINS AND METHODS OF USE
10/24/1996WO1996033268A1 Apopain
10/24/1996WO1996033220A1 Protective helicobacter antigens
10/24/1996WO1996033219A1 Monoclonal antibodies against hiv-1 and vaccines made thereof
10/24/1996WO1996033208A1 Antibody purification by low-ph hydrophobic interaction chromatoggraphy
10/24/1996WO1996033204A1 Multiple administrations of anti-tnf antibody
10/24/1996WO1996032965A1 Cd45rb binding compounds for the prevention of transplant rejection
10/24/1996WO1996032959A1 Cns neurite outgrowth modulators, and compositions, cells and methods embodying and using same
10/24/1996WO1996032956A1 p19: A CELL CYCLE INHIBITOR
10/24/1996WO1996032841A1 Novel therapeutic binding molecule complexes
10/24/1996CA2218741A1 Nucleotide sequence of the haemophilus influenzae rd genome, fragments thereof, and uses thereof
10/24/1996CA2218691A1 Novel therapeutic binding molecule complexes
10/24/1996CA2218679A1 Apopain
10/24/1996CA2218651A1 Repertoire cloning process, products derived therefrom and uses for said products
10/24/1996CA2218599A1 Cns neurite outgrowth modulators, and compositions, cells and methods embodying and using same
10/24/1996CA2218585A1 H. influenzae hxub and hxuc genes, proteins and methods of use
10/24/1996CA2218522A1 Multiple administrations of anti-tnf antibody
10/24/1996CA2217496A1 Protective helicobacter antigens
10/23/1996EP0738890A1 Method for measuring cholinesterase and method for distinguishing between liver cirrhosis and hepatitis
10/23/1996EP0738736A1 Monoclonal antibodies to gp130, and their uses
10/23/1996EP0738735A2 Aminoterminal propeptide of type I procollagen, antibody thereto and assay method using it
10/23/1996EP0738394A1 Ubiquitin conjugating enzymes
10/23/1996EP0738283A1 New polyaminocarboxylate chelators
10/23/1996EP0738282A1 Novel chimeric antibodies, their use and process for producing them
10/23/1996EP0738281A1 Peptides and methods against psoriasis
10/23/1996EP0738279A1 Novel bone and prostate-derived protein factors affecting prostate cancer growth, differentiation, and metastasis
10/23/1996EP0738277A1 Novel proteins which bind to retinoblastoma protein and their encoding dna sequences
10/23/1996EP0738156A1 Methods and compositions for inhibiting thrombogenesis
10/23/1996EP0640143A4 Senescent cell derived inhibitors of dna synthesis.
10/23/1996EP0528886B1 Beta cell antigen
10/23/1996EP0422125B1 Platelet blocking peptides
10/23/1996EP0416094B1 Parathyroid hypertensive factor
10/23/1996EP0276262B1 Merozoite surface antigen of plasmodium falciparum
10/23/1996CN1134172A Protocadherin proteins and their uses
10/23/1996CN1134159A Metal-bonding cystein-free peptides for diagnosis and therapy, process for producing them and pharmaceutical preparation contg. these compounds
10/23/1996CN1134113A Method for inducing antigen-specific T cell tolerance
10/23/1996CN1133886A Method for obtaining modified immunoglobulins with reduced immunogenicity of murine antibody variable domains and compositions containing them
10/22/1996US5567615 Affinity separation method
10/22/1996US5567609 Antigrowth agents
10/22/1996US5567603 HIV-3 retrovirus and its use
10/22/1996US5567584 Methods of using biologically active dimerized polypeptide fusions to detect PDGF
10/22/1996US5567582 Dna sequences
10/22/1996US5567317 Method to identify analyte-binding ligands
10/22/1996CA1338663C Biosynthetic osteogenic proteins and osteogenic devices containing them
10/17/1996WO1996032648A1 Method and device for diagnosing and distinguishing chest pain in early onset thereof
10/17/1996WO1996032641A1 Novel protein from dirofilaria immitis and method for immunodiagnosis of heartworm in mammals
10/17/1996WO1996032498A1 Phycobilisomes, derivatives, and uses therefor
10/17/1996WO1996032495A1 Monoclonal antibody specific for human 4-1bb and cell line producing same
10/17/1996WO1996032485A1 Phospholipase c homolog
10/17/1996WO1996032481A1 New chemokine expressed in eosinophils
10/17/1996WO1996032480A2 METHODS AND COMPOSITIONS FOR DETERMINING HER-2/neu EXPRESSION
10/17/1996WO1996032478A1 Altered polypeptides with increased half-life
10/17/1996WO1996032477A1 Genes encoding lymphocyte interferon regulatory factor (lsirf) polypeptides
10/17/1996WO1996032418A1 Anti-cd14 antibodies for use in the induction of il-10 secretion
10/17/1996WO1996032417A1 Antibodies against heart muscle actin
10/17/1996WO1996032416A1 Novel anti-aids immunotoxins
10/17/1996WO1996032137A2 Methods of inducing immune tolerance using immunotoxins
10/17/1996WO1996032128A1 Isolated 55 to 75 kda protein which binds to prion protein
10/17/1996WO1996032127A1 Methods of enhancing epithelial cell proliferation
10/17/1996WO1996032106A1 Aglyco products
10/17/1996WO1996023066A3 Prostaglandin receptor, dp
10/17/1996WO1996022371A3 C-C CHEMOKINE RECEPTOR 3: CKP-3 OR Eos-L2
10/17/1996WO1996021020A3 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases
10/17/1996CA2393381A1 Genes encoding lymphocyte interferon regulatory factor (lsirf) polypeptides
10/17/1996CA2217947A1 Isolated 55 to 75 kda protein which binds to prion protein
10/17/1996CA2217901A1 Phycobilisomes, derivatives, and uses therefor
10/17/1996CA2217025A1 New chemokine expressed in eosinophils
10/17/1996CA2216858A1 Phospholipase c homolog
10/17/1996CA2216210A1 Novel anti-aids immunotoxins
10/17/1996CA2215018A1 Method and device for diagnosing and distinguishing chest pain in early onset thereof
10/16/1996EP0737747A2 Cytoplasmatic expression in E. coli of antibodies, antibody fragments and fusions thereof
10/16/1996EP0737251A1 Antibodies to egf receptor and their antitumour effect
10/16/1996EP0737250A1 Humanized antibodies and uses thereof
10/16/1996EP0737209A1 Metal ion-ligand coordination complexes, antibodies directed thereto, and assays using such antibodies
10/16/1996EP0737208A1 Monoclonal antibodies specific for phf-tau, hybridomas secreting them, antigen recognition by these antibodies and their applications
10/16/1996EP0737075A1 Ileal bile acid transporter compositions and methods
10/16/1996EP0610179B1 Target specific antibody-superantigen conjugates and their preparation
10/16/1996EP0601062B1 Sirs vaccine and diagnosis method
10/16/1996EP0601052B1 Therapeutic method for the treatment of iddm
10/16/1996EP0543945B1 Methods and compositions for early detection and treatment of insulin dependent diabetes mellitus
10/16/1996EP0414755B1 Interaction system comprising a surfactant-stabilized disperse aqueous phase containing an antibody or antibody fragment
10/16/1996CN1133616A A novel nuclear mitotic phosphoprotein:mitosin
10/16/1996CN1133599A Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
10/16/1996CN1133594A Hsv-2 UL26 gene, capsid proteins, immunoassays and protease inhibitors
10/16/1996CN1133564A The Cloning of duffy blood group antigen
10/16/1996CN1033030C Preparation of macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates
10/15/1996US5565570 Chemiluminescent acridinium salts
10/15/1996US5565550 Antibodies to ICAM-2, and fragments thereof
10/15/1996US5565549 Retroviruse, aids
10/15/1996US5565548 Peptide having sequence of protective antibody-eliciting epitope and having mercapto groups linked to carrier comprising lipid vesicle containing amino moiety activated by polyaldehyde and cysteine
10/15/1996US5565356 Hybridoma cell lines which produce monoclonal antibodies having the properties of monoclonal antibody 100-310 and the monoclonal antibodies produced by these hybridoma cell lines
10/15/1996US5565354 For diagnosis and treatment of diseases caused by infection with hepatitis b virus
10/15/1996US5565338 Suppressor T-cell hybridoma and production of allergen specific glycosylation inhibiting factor
10/15/1996US5565335 Adhesion variants
10/15/1996US5565332 Production of chimeric antibodies - a combinatorial approach
1 ... 1326 1327 1328 1329 1330 1331 1332 1333 1334 1335 1336 1337 1338 1339 1340 1341 1342 1343 1344 1345 1346 ... 1494